Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Caleb Alexander

Showing results (241-250 of 414) with videos related to

Pageof 42
Sort By:
BMJ Open|June 11, 2020
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysisHemalkumar B Mehta, Stephan Ehrhardt, Thomas J Moore, et al.
O&G Open|September 26, 2025
Induced Abortion and Out-of-State Travel Among Insured Women Before and After the <i>Dobbs v. Jackson Women's Health Organization</i> DecisionIlina C Odouard, Jenny S Guadamuz, Apurba Chakraborty, et al.
Pharmacoepidemiology and Drug Safety|September 7, 2018
Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone usersIrene B Murimi, Hsien-Yen Chang, Mark Bicket, et al.
The Clinical Journal of Pain|June 24, 2015
Primary Care Physicians' Knowledge and Attitudes Regarding Prescription Opioid Abuse and DiversionCatherine S Hwang, Lydia W Turner, Stefan P Kruszewski, et al.
The American Journal of Managed Care|July 19, 2022
Medicare Advantage coverage restrictions for the costliest physician-administered drugsKelly E Anderson, G Caleb Alexander, Carolyne Ma, et al.
Allergy|October 26, 2022
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort studyAyobami Akenroye, Guohai Zhou, John W Jackson, et al.
Health Affairs Scholar|July 28, 2025
Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023Ilina C Odouard, So-Yeon Kang, Jessica Mo, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|October 29, 2013
Balancing burdens and benefits: ethical issues of off-label prescription pharmaceutical useFord Vox, Alexander M Capron, Marilyn F Kraus, et al.
Annals of Internal Medicine|September 28, 2020
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018James Heyward, Thomas J Moore, Jennifer Chen, et al.
JAMA Psychiatry|July 10, 2014
Emergency department visits by adults for psychiatric medication adverse eventsLee M Hampton, Matthew Daubresse, Hsien-Yen Chang, et al.
Pageof 42

Showing results (241-250 of 414) with videos related to

Sort By:
Pageof 42
BMJ Open|June 11, 2020
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysisHemalkumar B Mehta, Stephan Ehrhardt, Thomas J Moore, et al.
O&G Open|September 26, 2025
Induced Abortion and Out-of-State Travel Among Insured Women Before and After the <i>Dobbs v. Jackson Women's Health Organization</i> DecisionIlina C Odouard, Jenny S Guadamuz, Apurba Chakraborty, et al.
Pharmacoepidemiology and Drug Safety|September 7, 2018
Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone usersIrene B Murimi, Hsien-Yen Chang, Mark Bicket, et al.
The Clinical Journal of Pain|June 24, 2015
Primary Care Physicians' Knowledge and Attitudes Regarding Prescription Opioid Abuse and DiversionCatherine S Hwang, Lydia W Turner, Stefan P Kruszewski, et al.
The American Journal of Managed Care|July 19, 2022
Medicare Advantage coverage restrictions for the costliest physician-administered drugsKelly E Anderson, G Caleb Alexander, Carolyne Ma, et al.
Allergy|October 26, 2022
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort studyAyobami Akenroye, Guohai Zhou, John W Jackson, et al.
Health Affairs Scholar|July 28, 2025
Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023Ilina C Odouard, So-Yeon Kang, Jessica Mo, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|October 29, 2013
Balancing burdens and benefits: ethical issues of off-label prescription pharmaceutical useFord Vox, Alexander M Capron, Marilyn F Kraus, et al.
Annals of Internal Medicine|September 28, 2020
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018James Heyward, Thomas J Moore, Jennifer Chen, et al.
JAMA Psychiatry|July 10, 2014
Emergency department visits by adults for psychiatric medication adverse eventsLee M Hampton, Matthew Daubresse, Hsien-Yen Chang, et al.
Pageof 42